Altered phenotype and function of dendritic cells in children with type 1 diabetes

Autor: M. L. Manca Bitti, F. Angelini, Valentina Pacciani, Paolo Rossi, Simona Piccinini, E. Del Duca
Jazyk: angličtina
Rok vydání: 2005
Předmět:
Male
age distribution
Lipopolysaccharide
B7 antigen
T-Lymphocytes
Priming (immunology)
cell maturation
health status
HLA DR antigen
thymidine
Lymphocyte Activation
Pathogenesis
chemistry.chemical_compound
CD80
Clinical Studies
T lymphocyte
Immunology and Allergy
CD86
Child
time
Cells
Cultured

clinical article
Cultured
tritium
pathogenesis
lipopolysaccharide
article
Interleukin
Interleukin-12
Mixed
Interleukin-10
B7.1/ B7.2
Type 1 diabetes
Self Tolerance
priority journal
Child
Preschool

monocyte
Antigens
CD80

Dendritic Cells
Humans
Lymphocyte Culture Test
Mixed

Antigens
CD86

Infant
Diabetes Mellitus
Type 1

Adolescent
Immunophenotyping
Female
B7-1 Antigen
fluorescence
granulocyte macrophage colony stimulating factor
Type 1
medicine.medical_specialty
pediatrics
dendritic cell
phenotype
Cells
Immunology
cell stimulation
CD86 antigen
interleukin 10
interleukin 12
interleukin 4
adolescent
blood cell
cell culture
cell function
cell proliferation
child
concentration (parameters)
controlled study
DNA synthesis
female
human
human cell
immunity
infant
insulin dependent diabetes mellitus
male
molecule
protein expression
supernatant
umbilical cord blood
Biology
Internal medicine
medicine
Diabetes Mellitus
Antigens
Antigen-presenting cell
Lymphocyte Culture Test
Preschool
Autoimmune disease
Settore MED/38 - Pediatria Generale e Specialistica
Dendritic cell
medicine.disease
Colony-stimulating factor
Endocrinology
chemistry
Dendritic cells
B7-2 Antigen
Popis: SummaryThe importance of dendritic cells (DC) in the activation of T cells and in the maintenance of self-tolerance is well known. We investigated whether alterations in phenotype and function of DC may contribute to the pathogenesis of Type 1 diabetes (T1DM). Mature DC (mDC) from 18 children with T1DM and 10 age-matched healthy children were tested. mDC, derived from peripheral blood monocytes cultured for 6 days in presence of interleukin (IL)-4 and granulocyte-macrophage colony stimulating factor (GM-CSF) and stimulated with lipopolysaccharide (LPS) for the last 24 h, were phenotyped for the expression of the co-stimulatory molecules B7·1 and B7·2. In six patients and six controls allogenic mixed leucocyte reaction (AMLR) was performed using mDC and cord blood-derived naive T cells at a DC/T naive ratio of 1 : 200. Proliferation was assessed on day 7 by [3H]-thymidine incorporation assay. Mature DC derived from patients showed, compared with controls, a reduced expression of B7·1 [mean of fluorescence intensity (MFI): 36·2 ± 14·3 versus 72·9 ± 34·5; P = 0·004] and B7·2 (MFI: 122·7 ± 67·5 versus 259·6 ± 154·1; P = 0·02). We did not find differences in the HLA-DR expression (P = 0·07). Moreover, proliferative response of allogenic naive T cells cultured with mDC was impaired in the patients (13471 ± 9917·2 versus 40976 ± 24527·2 cpm, P = 0·04). We also measured IL-10 and IL-12 concentration in the supernatant of DC cultures. Interestingly, we observed in the patients a sevenfold higher level of IL-10 (P = 0·07) and a ninefold lower level of IL-12 (P = 0·01). Our data show a defect in the expression of the co-stimulatory molecules and an impairment of DC priming function, events that might contribute to T1DM pathogenesis.
Databáze: OpenAIRE